Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Gaush Meditech Ltd. ( (HK:2407) ).
Gaush Meditech Ltd reported a revenue of RMB653.1 million for the first half of 2025, marking a 1.7% increase from the previous year. The company’s net profit rose by 33.5% to RMB35.9 million, driven by a stable increase in research and development expenses, which accounted for a significant portion of the revenue, particularly in proprietary products. Despite the financial growth, the Board did not recommend an interim dividend payment.
More about Gaush Meditech Ltd.
Gaush Meditech Ltd is a company incorporated in the Cayman Islands, operating within the medical technology industry. The company focuses on proprietary medical products and services, with a significant emphasis on research and development.
Average Trading Volume: 152,684
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.08B
Learn more about 2407 stock on TipRanks’ Stock Analysis page.